Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pre-Op MRI Identifies Additional Breast Tumors

By MedImaging International staff writers
Posted on 31 May 2012
Newly diagnosed breast cancer patients should undergo a preoperative magnetic resonance imaging (MRI) scan even if their breasts are not dense, a new study revealed. The study found no difference between the usefulness of 3T breast MRI in detecting additional malignancies and high-risk lesions in dense vs. nondense breasts.

“There are currently no guidelines that define the role of breast density in determining if a preoperative MRI should be performed. However, anecdotally, we know that preoperative MRI exams tend to be ordered more frequently in younger patients and/or patients with dense breast tissue,” said Reena Vashi, MD, one of the authors of the study.

The study of 127 patients, conducted at Yale University School of Medicine (New Haven, CT, USA), found that 3T MRI detected additional malignancies in 26% of patients who had breasts that were not considered dense and in 25% of patients with dense breasts, said Dr. Vashi. There was no difference in the patients with dense breasts compared to those without dense breasts in regard “to the size of lesions detected, or the distribution of the lesions,” Dr. Vashi said. In both populations, a significant and statistically comparable percentage of patients had unsuspected additional cancers in the opposite breast or in a separate quadrant from the known cancer in the same breast, necessitating a change in surgical management.

This study provides motivation for more research, reported Dr. Vashi. “If these results are reproducible, we propose that the decision to perform preoperative breast MRI not be influenced by breast density,” she said.

The study was presented May 8, 2012, at the American Roentgen Ray Society annual meeting in Vancouver (BC, Canada).

Related Links:
Yale University School of Medicine


X-Ray Illuminator
X-Ray Viewbox Illuminators
X-ray Diagnostic System
FDX Visionary-A
MRI System
nanoScan MRI 3T/7T
40/80-Slice CT System
uCT 528

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.